Track topics on Twitter Track topics that are important to you
NEW YORK, July 24, 2015 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who purchased TrueCar, Inc. ("TrueCar" or the "Company") (NASDAQ:TRUE) securities between May 16, 2014 and May 20, 2015.
Click here to learn about the case: http://docs.wongesq.com/TRUE-Info-Request-Form-792. There is no cost or obligation to you.
The complaint alleges that defendants made false and/or misleading statements and/or failed to disclose that: (a) TrueCar's business practices violated unfair competition and deceptive trade practice laws; (b) TrueCar acts as a dealer and broker in car sales transactions without proper licensing, in violation of various States' laws that govern car sales; and as a result of the above (c) the Company's financial statements were materially false and misleading at all relevant times.
If you suffered a loss in TrueCar you have until July 27, 2015 to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email firstname.lastname@example.org, by telephone at 212.425.1140, or visit http://docs.wongesq.com/TRUE-Info-Request-Form-792.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: email@example.comNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...